The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.

2020-04-29T22:18:00+02:00

Contributo di Stefania Camastra The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. Martinussen C, Veedfald S, Dirksen C, Bojsen-Møller KN, Svane MS, Wewer

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.2020-04-29T22:18:00+02:00

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete

2020-04-22T14:01:45+02:00

Contributo di Valeria Guglielmi High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Alta prevalenza di obesità nei soggetti con infezione da SARS-CoV-2 che necessitano ventilazione

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete2020-04-22T14:01:45+02:00

A randomized, controlled trial of Liraglutide for adolescents with obesity

2020-04-15T18:04:11+02:00

Contributo: Paola Fierabracci A randomized, controlled trial of Liraglutide for adolescents with obesity. Commento a: A randomized, controlled trial of Liraglutide for adolescents with obesity. AS Kelly, P.Auerbach, M Barrrientos-Perez, I

A randomized, controlled trial of Liraglutide for adolescents with obesity2020-04-15T18:04:11+02:00

La biologia “integrata” del diabete di tipo II

2020-01-14T13:09:10+01:00

Contributo: Cappellari La biologia “integrata” del diabete di tipo II Titolo tradotto La biologia “integrata” del diabete di tipo II. Abstract tradotto Obesità e diabete di tipo II sono le patologie

La biologia “integrata” del diabete di tipo II2020-01-14T13:09:10+01:00

Le caratteristiche metaboliche del donatore determinano l’effetto del trapianto di microbiota fecale su sensibilità insulinica, consumo energetico e tempo di transito intestinale nel ricevente.

2020-01-14T13:04:17+01:00

Contributo: Guzzardi Le caratteristiche metaboliche del donatore determinano l’effetto del trapianto di microbiota fecale su sensibilità insulinica, consumo energetico e tempo di transito intestinale nel ricevente. Razionale. La chirurgia bariatrica, in

Le caratteristiche metaboliche del donatore determinano l’effetto del trapianto di microbiota fecale su sensibilità insulinica, consumo energetico e tempo di transito intestinale nel ricevente.2020-01-14T13:04:17+01:00

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete

2020-01-14T12:54:53+01:00

Contributo: Commento editoriale a cura di Angelo Cignarelli e Valentina A. Genchi Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete Breve razionale: la chirurgia

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete2020-01-14T12:54:53+01:00

Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.

2020-01-14T12:57:24+01:00

Contributo: Stefania Camastra Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. ABSTRACT In modelli animali, il Time-Restricted Feeding (TRF) può prevenire e risolvere vari aspetti

Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.2020-01-14T12:57:24+01:00

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data

2019-09-13T20:26:31+02:00

Contributo: Valeria Guglielmi Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data Confronto di efficacia

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data2019-09-13T20:26:31+02:00

Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.

2019-09-12T17:55:42+02:00

Contributo: Paola Fierabracci Commento a: Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Obes Surg.Epub 2019 Apr 25, Julià H,

Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.2019-09-12T17:55:42+02:00
Carica altri articoli

LOGIN SOCI